Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Innocan Pharma Corp announces a private placement of 535,000 units at C$1.87 per unit, raising up to C$1,000,000. The proceeds will be used for working capital and general corporate purposes.

PUBLIC · INNPFSep 09, 2026•about 2 hours ago

Amount Raised

$1 Million

Round Type

Seed

HerzliyaBiotechnologyHealth CarePharmaceuticalpharmaceuticals

Description

Innocan Pharma Corporation intends to complete a private placement of up to 535,000 units at a price of C$1.87 per unit for gross proceeds up to C$1,000,000. The offering is expected to close on or around September 17, 2026. Proceeds will be used for working capital and general corporate purposes, along with finder's fees. The units consist of common shares and purchase warrants.

Company Information

Company

INNOCAN PHARMA Corp

Location

1015, 926 - 5 AVENUE SW

Herzliya, Tel Aviv, Israel

About

Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies comprises with cannabinoids science, to treat various conditions to improve patients' quality of life. This segment involves two drug delivery technologies: (i) LPT CBD- loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for two indications: Epilepsy and Pain Management. (ii) CLX CBD-loaded exosomes platform that may hold the potential to provide a highly synergistic effect of regenerating and anti- inflammatory properties targeting the Central Nervous System (CNS). In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment Innocan has established a Joint Venture by the name of BI Sky Global Ltd. that focuses developing on advanced targeted online sales. https://innocanpharma.com/

Don't miss INNOCAN PHARMA Corp's next move

Get an email the moment INNOCAN PHARMA Corp raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Verified contactsIris B., Executive Officer, Director
Predictive Intelligence
Strategic

ML-powered predictions for INNOCAN PHARMA Corp's next move

See what Strategic adds

INNOCAN PHARMA Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.